glp 1 multiple endocrine neoplasia Glucagon-like peptide receptor agonists and cancer risk: advancing precision medicine through mechanistic understanding and clinical evidence | Biomarker Research GLP-1 receptor agonists and DPP-4

GLP-1 medications are a high-cost option and must be managed appropriately to ensure patients achieve the desired response

If this situation arises, it's worth asking directly whether the referral is medically necessary or whether your PCP can manage the prescription, with specialist consultation available if required

The most common plan of action has been to hold the GLP-1 RA for at least the first cycle to monitor for unwanted effects

Polonsky, PhD, CDCES, and Susan Guzman, PhD , from the Behavioral Diabetes Institute reveal the hidden psychosocial forces that drive or derail diabetes self-management

Non-arteritic anterior ischemic optic neuropathy, or NAION, is a condition where blood flow to your optic nerve suddenly decreases